• Ugidos IF, González-Rodríguez P, Santos-Galdiano M, Font-Belmonte, Anuncibay-Soto B, Pérez-Rodríguez D, Gonzalo-Orden JM, Fernández-López A (2023). The neuroprotective effect of meloxicam in a transient ischemia model: the two faces of the anti-inflammatory treatments after stroke. Neural Regen Res 18(9):1961-1967. DOI:10.4103/1673-5374.367846.
• González-Rodríguez P, Fernández-López A. 2023. PANoptosis: New insights in regulated cell death in ischemia/reperfusion models. Neural Regen Res 18(2): 343-343. DOI: 10.4103/1673-5374.343910
• Fernández-López A, Balboa Arregui, O, Tejada J. 2022. Inflammation and stroke. In “Horizons in Neuroscience Research”. Vol 48. Ed. A Costa & E. Vlllalba. Nova. ISBN: 979-8-88697-230-6
• Mourenza A, Lorente-Torres B, Durante E, Llano-Verdeja J, Aparicio J, Fernández-López A, Gil JA, Mateos LM, Letek, M. Understanding microRNAs in the context of infection to find new treatments against human bacterial pathogens. Antibiotics 11: 356. DOI: https://doi.org/10.3390/antibiotics11030356
• Santos-Galdiano M, Pérez-Rodríguez D, Fernández-López A. 2022. Celeboxib-mediated neuroprotection in focal cerebral ischemia: an interplay between unfolded protein response and inflammation. Neural Regen Res 17:302-303 DOI: 10.4103/1673-5374.317970.
• Santos-Galdiano M, González-Rodríguez P, Font-Belmonte E, Ugidos IF, Anuncibay-Soto B, Pérez-Rodríguez D, Fernández-López A. 2021. Celecoxib-dependent neuroprotection in a rat model of transient middle cerebral artery occlusion (tMCAO) involves modifications in unfolded protein response (UPR) and proteasome. Mol Neurobiol 58(4):1404-1417. DOI: 10.1007/s12035-020-02202-y
• Font-Belmonte E, González-Rodriguez P, Fernández-López A. 2020. Necroptosis in global cerebral ischemia. A role for endoplasmic reticulum stress. Neural Regen Res  15(3):455-456. DOI: 10.4103/1673-5374.266054.
• Font-Belmonte E, Ugidos IF, Santos-Galdiano M, González-Rodríguez P, Anuncibay-Soto B, Pérez-Rodríguez D, Gonzalo-Orden JM, Fernández-López A. 2019. Post-ischemic salubrinal administration reduces necroptosis in a rat model of global cerebral ischemia. J Neurochem 151(6): 777-794. DOI: 10.1111/JNC.14789
• Anuncibay-Soto B, Font-Belmonte E, Fernández-López A. 2019. Combining anti-inflammatory and unfolding responses to fight stroke. Neural Regen Res  14(3):450-451. DOI: 10.4103/1673-5374.245468.
• Landucci E, Llorente IL, Anuncibay-Soto B, Pellegrini-Giampietro DE, Fernández-López A. 2019. Using organotypic hippocampal slice cultures to gain insight into mechanisms responsible for the neuroprotective effects of meloxicam. Neural Regen Res  14(1):65-66.  DOI: 10.4103/1673-5374.243704
• Santos-Galdiano M,  Pérez-Rodríguez D, Anuncibay-Soto B, Font-Belmonte E,  Ugidos IF, Pérez-García CC, Fernández-López A. 2018. Celecoxib treatment improves neurological deficit and reduces selective neuronal loss and glial response in rats following transient middle cerebral artery occlusion. J Pharmacol Exp Ther  367(3):528-542. DOI: https://doi.org/10.1124/jpet.118.251264
• González-Rodríguez P, Ugidos IF, Pérez-Rodríguez D, Anuncibay-Soto B, Santos-Galdiano M, Font-Belmonte E, Gonzalo-Orden JM, Fernández-López A. 2019. Brain-derived neurotrophic factor alleviates the oxidative stress induced by oxygen and glucose deprivation in an ex vivo brain slice model. J Cell Physiol 234(6): 9592-9604. DOI: 10.1002/jcp.27646
• Landucci E, Llorente IL, Anuncibay-Soto B, Pellegrini-Giampietro DE, Fernández-López A. 2018. Bicuculline reverts the neuroprotective effect of meloxicam in an oxygen and glucose deprivation (OGD) model of organotypic hippocampal slice cultures. Neuroscience 386:68-78. doi: 10.1016/j.neuroscience.2018.06.024
• Maldonado P, Chánez-Cárdena, ME, Fernández-López A. 2018. Mechanism of cell damage in neurological diseases and putative neuroprotective strategies. Oxid Med Cell Longev 2018:9784319. doi: 10.1155/2018/9784319.
• Anuncibay-Soto B, Perez-Rodriguez D, Santos-Galdiano M, Font-Belmonte E, Ugidos IF, Gonzalez-Rodriguez P, Regueiro-Purriños M, Fernández-López A. 2018. Salubrinal and robenacoxib treatment after global cerebral ischemia. Exploring the interactions between ER stress and inflammation. Biochem Pharmacol 151:26-37. doi: 10.1016/j.bcp.2018.02.029.
• Ugidos IF, Pérez-Rodríguez D, Fernández-López A. 2017. A role for lipids as agents to alleviate stroke damage: the neuroprotective effect of 2-hydroxy arachidonic acid. Neural Regen Res 12(8):1273-1275. doi: 10.4103/1673-5374.213545.
• Ugidos IF, Santos-Galdiano M, Pérez-Rodríguez D, Anuncibay-Soto B, Font-Belmonte E, López DJ, Ibarguren M, Busquets X, Fernández-López A. 2017. Neuroprotective effect of 2-hydroxy arachidonic acid in a rat model of transient middle cerebral artery occlusion. Biochem Biophys Acta 1859(9 Pt B):1648-1656. DOI: 10.1016/j.bbamem.2017.03.009
• Anuncibay-Soto, B, Santos-Galdiano M, Fernández-López A. 2016. Neuroprotection by salubrinal treatment in global cerebral ischemia. Neural Regen Res 11(11):1744-1745. doi: 10.4103/1673-5374.194711.
• Anuncibay-Soto B, Pérez-Rodríguez D, Santos-Galdiano M. Font E, Regueiro-Purriños M, Fernández-López A. 2016. Post-ischemic salubrinal treatement results in a neuroprotective role in global cerebral ischemia. J Neurochem 138(2):295-306.
• Klionsky DJ et al., 2016. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition. Autophagy 12(1):1-222. doi:10.1080/15548627.2015.1100356.
• Llorente IL, Landucci E, Pellegrini-Giampietro DE, Fernández-López A. 2015. Glutamate receptor and transporter modifications in rat organotypic hippocampal slice cultures exposed to oxygen-glucose deprivation: the contribution of cyclooxygenase-2. Neuroscience 292:118-28.